Literature DB >> 26568154

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

Stephen W Erickson1, Owen W Stephens2, Shweta S Chavan2, Joshua Epstein2, Bart Barlogie2, Christoph J Heuck2, Annette J Vangsted3.   

Abstract

Entities:  

Keywords:  genetic variants; myeloma; outcome

Mesh：

Substances：

Year:  2015        PMID： 26568154     DOI： 10.1111/bjh.13830

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Genetically determined telomere length and multiple myeloma risk and outcome.

Authors:  Federico Canzian; Daniele Campa; Matteo Giaccherini; Angelica Macauda; Enrico Orciuolo; Marcin Rymko; Karolina Gruenpeter; Charles Dumontet; Malgorzata Raźny; Victor Moreno; Gabriele Buda; Katia Beider; Judit Varkonyi; Hervé Avet-Loiseau; Joaquín Martinez-Lopez; Herlander Marques; Marzena Watek; Maria Eugenia Sarasquete; Vibeke Andersen; Lionel Karlin; Anna Suska; Marcin Kruszewski; Niels Abildgaard; Marek Dudziński; Aleksandra Butrym; Arnold Nagler; Annette Juul Vangsted; Katalin Kadar; Tomczak Waldemar; Krzysztof Jamroziak; Svend Erik Hove Jacobsen; Lene Hyldahl Ebbesen; Michał Taszner; Grzegorz Mazur; Fabienne Lesueur; Matteo Pelosini; Ramon Garcia-Sanz; Artur Jurczyszyn; Delphine Demangel; Rui Manuel Reis; Elżbieta Iskierka-Jażdżewska; Miroslaw Markiewicz; Federica Gemignani; Edyta Subocz; Daria Zawirska; Agnieszka Druzd-Sitek; Anna Stępień; M Henar Alonso; Juan Sainz
Journal:  Blood Cancer J       Date:  2021-04-14       Impact factor: 11.037

2.  A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes.

Authors:  Maia van Kan; Kathryn E Burns; Nuala A Helsby
Journal:  Cancer Chemother Pharmacol       Date:  2021-08-04       Impact factor: 3.333

3.  Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.

Authors:  Angelica Macauda; Chiara Piredda; Alyssa I Clay-Gilmour; Juan Sainz; Gabriele Buda; Miroslaw Markiewicz; Torben Barington; Elad Ziv; Michelle A T Hildebrandt; Alem A Belachew; Judit Varkonyi; Witold Prejzner; Agnieszka Druzd-Sitek; John Spinelli; Niels Frost Andersen; Jonathan N Hofmann; Marek Dudziński; Joaquin Martinez-Lopez; Elzbieta Iskierka-Jazdzewska; Roger L Milne; Grzegorz Mazur; Graham G Giles; Lene Hyldahl Ebbesen; Marcin Rymko; Krzysztof Jamroziak; Edyta Subocz; Rui Manuel Reis; Ramon Garcia-Sanz; Anna Suska; Eva Kannik Haastrup; Daria Zawirska; Norbert Grzasko; Annette Juul Vangsted; Charles Dumontet; Marcin Kruszewski; Magdalena Dutka; Nicola J Camp; Rosalie G Waller; Waldemar Tomczak; Matteo Pelosini; Małgorzata Raźny; Herlander Marques; Niels Abildgaard; Marzena Wątek; Artur Jurczyszyn; Elizabeth E Brown; Sonja Berndt; Aleksandra Butrym; Celine M Vachon; Aaron D Norman; Susan L Slager; Federica Gemignani; Federico Canzian; Daniele Campa
Journal:  Int J Cancer       Date:  2021-03-30       Impact factor: 7.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.